0
Your cart

Your cart is empty

Books > Business & Economics > Economics

Buy Now

Pharmaceutical Public Policy (Paperback) Loot Price: R1,057
Discovery Miles 10 570
Pharmaceutical Public Policy (Paperback): Thomas R. Fulda, Alan Lyles, Albert I Wertheimer

Pharmaceutical Public Policy (Paperback)

Thomas R. Fulda, Alan Lyles, Albert I Wertheimer

 (sign in to rate)
Loot Price R1,057 Discovery Miles 10 570 | Repayment Terms: R99 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

As the most common health-care intervention, prescription drug use shares the most important characteristics of the health-care system in the United States. When everything works well, it makes possible breathtakingly successful applications of science to the prevention and cure of human suffering. But everything doesn't always work well. Pharmaceutical Public Policy provides the understanding and framework required for effective organization, financing, and delivery of pharmaceutical products and services. It supplies an overview of the policy process as well as the roles of legislation and regulation in pharmaceutical policy. The book identifies the goals, objectives, and key policy issues of concern to stakeholders involved in the development of products, use of pharmaceuticals in healthcare, and administration of insurance programs by both the private and government sectors. Policy issues examined include the appropriateness of prescribing and patient adherence. Addressing questions of access, quality, and cost, the book considers the operation of the Affordable Care Act and Medicare Part D. It details the responsibilities of Federal providers of pharmaceutical care and private and public payers such as managed care organizations, pharmacy benefit managers, Medicare, and Medicaid. The book covers the policies and practices involved in promoting pharmaceutical products. It also considers pharmacoeconomics as a response to market failure. Finally, the book describes the market, the role of the manufacturer, drug shortages, and the responsibilities of the FDA. The book includes a Foreword by Jerry Avorn, MD, Professor of Medicine, Harvard Medical School; and Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Woman's Hospital.

General

Imprint: Taylor & Francis
Country of origin: United Kingdom
Release date: December 2021
First published: 2016
Authors: Thomas R. Fulda • Alan Lyles • Albert I Wertheimer
Dimensions: 254 x 178mm (L x W)
Format: Paperback
Pages: 514
ISBN-13: 978-1-03-224251-4
Categories: Books > Social sciences > Politics & government > General
Books > Business & Economics > Economics > General
Books > Science & Mathematics > Biology, life sciences > General
Books > Business & Economics > Business & management > Ownership & organization of enterprises > Public ownership / nationalization
Books > Medicine > General issues > Health systems & services > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 1-03-224251-5
Barcode: 9781032242514

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners